title: JUBLIA (Efinaconazole): An Update.
authors: Department of Medicine, University of Toronto School of Medicine, Toronto, Ontario, Canada, Dallas, TX; agupta@execulink.com.|Mediprobe Research Inc, London, Ontario, Canada, Dallas, TX.
authors: Aditya K
authors: AK
authors: Gupta
authors: Mediprobe Research Inc, London, Ontario, Canada, Dallas, TX.
authors: Maria
authors: M
authors: Cernea
authors: Department of Medicine, Baylor University Medical Center, Dallas, TX.|Departments of Dermatology and Family Practice, University of Texas Southwestern Medical School, Dallas, TX.|Dermatology Treatment and Research Center, Dallas, TX.
authors: William
authors: W
authors: Abramovits
mesh_terms: D000287:Administration, Topical; D000935:Antifungal Agents / Q000627:therapeutic use*; D006801:Humans; D014009:Onychomycosis / Q000188:drug therapy; D014230:Triazoles / Q000627:therapeutic use*
chemical_list: D000935:Antifungal Agents; D014230:Triazoles; C431707:efinaconazole